Mandate

Vinge advises ABG, SEB and Swedbank in connection with a directed share issue in Hemfosa

June 20, 2018

Vinge advises ABG Sundal Collier, Skandinaviska Enskilda Banken and Swedbank who are acting as Joint Lead Managers and Bookrunners in connection with Hemfosa Fastigheter’s directed share issue, on the basis of an authorisation from the annual general meeting, of 10 million common shares, raising proceeds of SEK 1,085 million.

Hemfosa Fastigheter is a Swedish property company focused on community service properties in the Nordic region, with its largest tenants being the Swedish state and municipalities. Hemfosa’s common share has been listed since March 2014 and its preference share since December 2014, both on Nasdaq Stockholm.
 
Vinge’s team consists of Erik Sjöman, Dain Hård Nevonen and Sofie Bjärtun.
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025